PHS
EW icon

PFM Health Sciences’s Edwards Lifesciences EW Stock Holding History

PFM Health Sciences’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-525,400
Closed -$38.9M – 74
2024
Q4 		$38.9M Buy
+525,400
New +$36.8M 2.41% 13
2019
Q2 		– Sell
-469,500
Closed -$29.9M – 91
2019
Q1 		$29.9M Buy
+469,500
New +$26.8M 0.66% 55

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

PFM Health Sciences's EW Position: Q2 2026 in Review

PFM Health Sciences reduced its Edwards Lifesciences (EW) stake by 1.6% in Q2 2026, selling an estimated $340K and leaving 250,453 shares worth $22.7M. The position accounts for 1.94% of the portfolio, ranked #13.

PFM Health Sciences first reported a position in EW in Q4 2014 and has held it in 47 quarters since. The position peaked at $127M in Q2 2015. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • PFM Health Sciences held 250,453 shares of Edwards Lifesciences worth $22.7M as of Q2 2026.
  • PFM Health Sciences sold 4,057 Edwards Lifesciences shares in Q2 2026, an estimated $340K.
  • Edwards Lifesciences made up 1.94% of PFM Health Sciences's portfolio in Q2 2026, its #13 holding.
  • PFM Health Sciences first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 47 quarters since.
  • PFM Health Sciences's Edwards Lifesciences position peaked at $127M in Q2 2015.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.